Matches in Wikidata for { <http://www.wikidata.org/entity/Q64723041> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q64723041 description "clinical trial" @default.
- Q64723041 description "ensayu clínicu" @default.
- Q64723041 description "klinisch onderzoek" @default.
- Q64723041 description "клінічне випробування" @default.
- Q64723041 name "Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma" @default.
- Q64723041 type Item @default.
- Q64723041 label "Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma" @default.
- Q64723041 prefLabel "Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma" @default.
- Q64723041 P1050 Q64723041-546FE11D-DEEE-4FE4-8226-AD02621371A9 @default.
- Q64723041 P1132 Q64723041-09BEDD00-20FC-4C1A-B0DA-9CEC9A56CB91 @default.
- Q64723041 P1476 Q64723041-1C40B186-5439-4845-8513-B5AE884B8EFB @default.
- Q64723041 P17 Q64723041-9B6DBFFC-40FA-4328-81BA-FB4441EAC8BF @default.
- Q64723041 P1813 Q64723041-42675FC3-AE7C-46F3-AEA8-A1F03D9B4662 @default.
- Q64723041 P2899 Q64723041-2607F039-7542-456A-9780-2ED61EB10C05 @default.
- Q64723041 P3098 Q64723041-458FBA39-EA3A-43F8-94B9-A6D7C7B374CF @default.
- Q64723041 P31 Q64723041-B5ECA9A7-F6E3-4047-A0A5-0540D19F5103 @default.
- Q64723041 P4844 Q64723041-593F16D1-940F-4543-B71B-E74AC18478BC @default.
- Q64723041 P4844 Q64723041-77D632DA-F547-45E6-BC44-4A7E0CDAC084 @default.
- Q64723041 P4844 Q64723041-EBDBC230-E6C1-4F91-A20F-6B0C7ACD340D @default.
- Q64723041 P580 Q64723041-387E9528-66FB-498A-A326-FC46C59CFED8 @default.
- Q64723041 P582 Q64723041-20F45CA9-C9A1-41BE-AC12-6B96F5AF19BB @default.
- Q64723041 P6099 Q64723041-7A8CC634-AF5C-4EA5-B27C-5B18CF68A639 @default.
- Q64723041 P6153 Q64723041-2B88A433-C07A-4A97-AC69-2D0029B6550D @default.
- Q64723041 P6153 Q64723041-7FD9C29A-11AE-47AC-B75A-8FD39F3B065D @default.
- Q64723041 P6153 Q64723041-9CD3C1FC-F6FA-464A-B7FD-48F9C67AEDAA @default.
- Q64723041 P6153 Q64723041-B1E86FA7-7BE1-4226-825C-931EE9EDB426 @default.
- Q64723041 P8363 Q64723041-D28EA5A9-7A1A-4FE6-94E7-FBCDF7B7D189 @default.
- Q64723041 P859 Q64723041-4F8CE54E-5154-4074-9095-8D8D8DBFEFC4 @default.
- Q64723041 P1050 Q33525 @default.
- Q64723041 P1132 "+160" @default.
- Q64723041 P1476 "Open Label, Randomized, Multicenter Phase II Study of a Combination of Torisel® (Temsirolimus) and Avastin® (Bevacizumab) Versus Sutent® (Sunitinib) and Versus a Combination of Avastin® (Bevacizumab) and Roféron® (Interferon Alpha-2a) in First-line Treatment of Patients With Metastatic Renal Cell Carcinoma." @default.
- Q64723041 P17 Q142 @default.
- Q64723041 P1813 "TORAVA" @default.
- Q64723041 P2899 "+18" @default.
- Q64723041 P3098 "NCT00619268" @default.
- Q64723041 P31 Q30612 @default.
- Q64723041 P4844 Q20817235 @default.
- Q64723041 P4844 Q32089 @default.
- Q64723041 P4844 Q413299 @default.
- Q64723041 P580 "2008-02-01T00:00:00Z" @default.
- Q64723041 P582 "2012-02-01T00:00:00Z" @default.
- Q64723041 P6099 Q42824440 @default.
- Q64723041 P6153 Q266227 @default.
- Q64723041 P6153 Q2944826 @default.
- Q64723041 P6153 Q30296137 @default.
- Q64723041 P6153 Q3151727 @default.
- Q64723041 P8363 Q78089383 @default.
- Q64723041 P859 Q2944832 @default.